 |
TOTAL (ISIN : FR0000120271) |
|
|
 |
|
Total:Third Quarter 2009 Results
|
|
(04/11/09 10:35 CET)
|
|
Regulatory News:
Main results
1-2
|
-- Third quarter adjusted net income3
|
|
1.9 billion euros
|
|
-54%
|
|
|
2.7 billion dollars
|
|
-56%
|
|
|
0.84 euros per share
|
|
-54%
|
|
|
1.20 dollars per share
|
|
-56%
|
|
-- First nine months adjusted net income
|
|
5.7 billion euros
|
|
-48%
|
|
|
7.8 billion dollars
|
|
-54%
|
|
-- First nine months net income (Group share)
|
|
6.4 billion euros
|
|
-44%
|
Highlights since the beginning of the third quarter 2009
-
Upstream production of 2,243 kboe/d in the third quarter 2009
-
Started up production at Tyrihans in Norway, Tombua Landana in
Angola, Qatargas II Train B and Yemen LNG
-
Algerian authorities approved development plan for Timimoun gas
field
-
Declaration of commerciality filed for the Itau gas field in
Bolivia
-
Signed gas sales contract allowing the development of the
Greater Bongkot South field in Thailand
-
Announced Gardenia-1, first oil discovery on Block 17/06 in
Angola
-
Acquisition of a 43.75% interest in the UK Shetlands P967 block
that includes the Tobermory gas discovery
-
Signed an agreement with KazMunaiGas to take a 17% interest in
the development of the Khvalynskoye gas field in the Caspian Sea
-
Creation of joint research partnerships with IMEC and the French
National Center for Scientific Research together with l’Ecole
Polytechnique to focus on solar photovoltaic technology
The Board of Directors of Total (Paris:FP) (LSE:TTA) (NYSE:TOT), led by
Chairman Thierry Desmarest, met on November 3, 2009 to review the
Group’s third quarter 2009 results.
Adjusted net income was 1,869 million euros (M€), a decrease of 54%
compared to the third quarter 2008 and an increase of 9% compared to
second quarter 2009.
Commenting on the results, CEO Christophe de Margerie said :
« In the third quarter, the average Brent price increased to 68 $/b.
However, spot gas prices and refining margins reached very low levels,
reflecting the sharp decline in demand and the resulting oversupply. The
Chemicals segment benefited from a small improvement in margins.
In this mixed environment, Total’s adjusted net income was 2.7
billion dollars, an increase of 14% compared to the second quarter 2009.
Compared to the third quarter 2008, when oil prices hit record highs,
the Group’s results are down 56%, but, once again, they show resilience
that is among the best of the peer group. In the third quarter 2009, the
Group generated net cash flow of 3 billion dollars and reduced its
gearing to 21%.
In the Upstream, Total’s production is back on track with growth of
3% from the second quarter to 2,243 kboe/d, thanks in
particular to the ramp up of Akpo in Nigeria and Tahiti in the Gulf of
Mexico as well as the start-up of Tyrihans in Norway, Tombua Landana in
Angola and Qatargas 2 Train B. The mid-October start-up of Yemen LNG
completes the Group’s objective to start up its 2009 major projects.
Total is also pursuing the development of new fields and took
decisive steps during the quarter on projects in Bolivia, Algeria and
Thailand. The recent agreement with KazMunaïGas in the Caspian Sea, like
the one signed with Novatek in Russia in the previous quarter, also
illustrates the Group’s ability to create partnerships and to
participate in the development of new resources by leveraging its
technical expertise and its capacity for investment. At the same time,
the Upstream segment is continuing to actively implement cost reduction
programs targeting its fixed costs and the projected cost of its
investments.
In the Downstream segment, refining is faced with a very difficult
environment. We are working to reduce costs and restore the
profitability of this activity. In the Chemicals segment, the benefits
of our restructuring efforts can be seen in the sequential improvement
in the results despite an environment that remains difficult.
Total is determined to pursue its strategy of profitable and
responsible growth, while reaffirming the priority of safety and the
environment. Combining the key elements of reliability and safety in our
operations and production growth with cost reduction will allow us to
successfully implement our strategy.
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of euros
except earnings per share and
number of shares
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
33,628
|
|
31,430
|
|
48,849
|
|
-31%
|
|
Sales
|
|
95,099
|
|
141,262
|
|
-33%
|
|
3,510
|
|
3,044
|
|
8,083
|
|
-57%
|
|
Adjusted operating income from business segments
|
|
10,169
|
|
22,988
|
|
-56%
|
|
1,808
|
|
1,678
|
|
4,063
|
|
-56%
|
|
Adjusted net operating income from business segments
|
|
5,536
|
|
11,019
|
|
-50%
|
|
1,501
|
|
1,451
|
|
2,899
|
|
-48%
|
|
= Upstream
|
|
4,434
|
|
8,729
|
|
-49%
|
|
146
|
|
156
|
|
901
|
|
-84%
|
|
= Downstream
|
|
902
|
|
1,799
|
|
-50%
|
|
161
|
|
71
|
|
263
|
|
-39%
|
|
= Chemicals
|
|
200
|
|
491
|
|
-59%
|
|
1,869
|
|
1,721
|
|
4,070
|
|
-54%
|
|
Adjusted net income
|
|
5,703
|
|
11,047
|
|
-48%
|
|
0.84
|
|
0.77
|
|
1.81
|
|
-54%
|
|
Adjusted fully-diluted earnings per share (euros)
|
|
2.55
|
|
4.91
|
|
-48%
|
|
2,236.8
|
|
2,235.6
|
|
2,244.3
|
|
-
|
|
Fully-diluted weighted-average shares (millions)
|
|
2,235.9
|
|
2,250.4
|
|
-1%
|
|
1,923
|
|
2,169
|
|
3,050
|
|
-37%
|
|
Net income (Group share)
|
|
6,382
|
|
11,384
|
|
-44%
|
|
3,256
|
|
3,634
|
|
3,371
|
|
-3%
|
|
Investments5
|
|
9,825
|
|
8,882
|
|
+11%
|
|
3,169
|
|
3,575
|
|
3,195
|
|
-1%
|
|
Investments including net investments in equity affiliates and
non-consolidated companies
5
|
|
9,584
|
|
7,879
|
|
+22%
|
|
807
|
|
858
|
|
718
|
|
+12%
|
|
Divestments
|
|
2,137
|
|
1,642
|
|
+30%
|
|
4,538
|
|
1,939
|
|
7,338
|
|
-38%
|
|
Cash flow from operations
|
|
10,471
|
|
14,576
|
|
-28%
|
|
3,454
|
|
3,237
|
|
5,642
|
|
-39%
|
|
Adjusted cash flow from operations
|
|
10,063
|
|
14,771
|
|
-32%
|
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of dollars
6
except
earnings per share and number of shares
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
48,098
|
|
42,845
|
|
73,518
|
|
-35%
|
|
Sales
|
|
129,953
|
|
214,958
|
|
-40%
|
|
5,020
|
|
4,150
|
|
12,165
|
|
-59%
|
|
Adjusted operating income from business segments
|
|
13,896
|
|
34,981
|
|
-60%
|
|
2,586
|
|
2,287
|
|
6,115
|
|
-58%
|
|
Adjusted net operating income from business segments
|
|
7,565
|
|
16,768
|
|
-55%
|
|
2,147
|
|
1,978
|
|
4,363
|
|
-51%
|
|
= Upstream
|
|
6,059
|
|
13,283
|
|
-54%
|
|
209
|
|
213
|
|
1,356
|
|
-85%
|
|
= Downstream
|
|
1,233
|
|
2,738
|
|
-55%
|
|
230
|
|
97
|
|
396
|
|
-42%
|
|
= Chemicals
|
|
273
|
|
747
|
|
-63%
|
|
2,673
|
|
2,346
|
|
6,125
|
|
-56%
|
|
Adjusted net income
|
|
7,793
|
|
16,810
|
|
-54%
|
|
1.20
|
|
1.05
|
|
2.73
|
|
-56%
|
|
Adjusted fully-diluted earnings per share (dollars)
|
|
3.49
|
|
7.47
|
|
-53%
|
|
2,236.8
|
|
2,235.6
|
|
2,244.3
|
|
-
|
|
Fully-diluted weighted-average shares (millions)
|
|
2,235.9
|
|
2,250.4
|
|
-1%
|
|
2,750
|
|
2,957
|
|
4,590
|
|
-40%
|
|
Net income (Group share)
|
|
8,721
|
|
17,323
|
|
-50%
|
|
4,657
|
|
4,954
|
|
5,073
|
|
-8%
|
|
Investments5
|
|
13,426
|
|
13,516
|
|
-1%
|
|
4,533
|
|
4,873
|
|
4,808
|
|
-6%
|
|
Investments including net investments in equity affiliates and
non-consolidated companies
5
|
|
13,097
|
|
11,989
|
|
+9%
|
|
1,154
|
|
1,170
|
|
1,081
|
|
+7%
|
|
Divestments
|
|
2,920
|
|
2,499
|
|
+17%
|
|
6,491
|
|
2,643
|
|
11,044
|
|
-41%
|
|
Cash flow from operations
|
|
14,309
|
|
22,180
|
|
-35%
|
|
4,940
|
|
4,413
|
|
8,491
|
|
-42%
|
|
Adjusted cash flow from operations
|
|
13,751
|
|
22,477
|
|
-39%
|
-
Third quarter 2009 results
>
Operating income
In the third quarter 2009, the Brent price averaged 68.1 $/b, a decrease
of 41% compared to the third quarter 2008 and an increase of 15%
compared to the second quarter 2009. The TRCV European refining margin
indicator fell to 6.6 $/t on average in the third quarter 2009, a
decrease of 85% compared to the third quarter 2008 and 47% compared to
the second quarter 2009.
The euro-dollar exchange rate averaged 1.43 $/€ in the third quarter
2009 compared to 1.51 $/€ in the third quarter 2008 and 1.36 $/€ in the
second quarter 2009.
In this environment, the adjusted operating income from the business
segments was 3,510 M€, a decrease of 57% compared to the third quarter
20087. Expressed in dollars, the decrease was 59%.
The effective tax rate8 for the business segments was 57% in
the third quarter 2009 compared to 56% in the third quarter 2008.
Adjusted net operating income from the business segments was 1,808 M€
compared to 4,063 M€ in the third quarter 2008, a decrease of 56%.
Expressed in dollars, adjusted net operating income from the business
segments was 2.6 billion dollars (B$), a decrease of 58% compared to the
third quarter 2008.
>
Net income
Adjusted net income was 1,869 M€ compared to 4,070 M€ in the third
quarter 2008, a decrease of 54%. Expressed in dollars, adjusted net
income decreased by 56%. It excludes the after-tax inventory effect,
special items, and the Group’s equity share of adjustments and selected
items related to Sanofi-Aventis.
-
The after-tax inventory effect had a positive impact on net income of
122 M€ in the third quarter 2009 and a negative effect of 752 M€ in
the third quarter 2008.
-
The Group’s share of adjustments and selected items related to
Sanofi-Aventis had a negative impact on net income of 70 M€ in the
third quarter 2009. The adjustments related to Sanofi-Aventis had a
negative impact of 78 M€ in the third quarter 2008.
-
Other special items had a positive impact on net income of 2 M€ in the
third quarter 2009. In the third quarter 2008, other special items had
a negative impact on net income of 190 M€9.
Reported net income (Group share) was 1,923 M€ compared to 3,050 M€ in
the third quarter 2008.
The effective tax rate for the Group was 56.5% in the third quarter 2009.
The Group did not buy back shares in the third quarter 2009.
Adjusted fully-diluted earnings per share, based on 2,236.8 million
fully-diluted weighted-average shares, was 0.84 euros compared to 1.81
euros in the third quarter 2008, a decrease of 54%.
Expressed in dollars, adjusted fully-diluted earnings per share fell by
56% to $1.20.
>
Investments – divestments
10
Investments excluding acquisitions and including net investments in
equity affiliates and non-consolidated companies were 3.1 B€ (4.4 B$) in
the third quarter 2009 compared to 2.8 B€ (4.2 B$) in the third quarter
2008.
Acquisitions were 58 M€ in the third quarter 2009.
Asset sales in the third quarter 2009 were 702 M€, consisting
essentially of Sanofi-Aventis shares.
Net investments11 were 2.4 B€ (3.5 B$) in the third quarter
2009 compared to 2.7 B€ (4.0 B$) in the third quarter 2008.
>
Cash flow
Cash flow from operating activities was 4,538 M€ in the third quarter
2009 compared to 7,338 M€ in the third quarter 2008. The 38% decrease
was mainly due to the decrease in net income and a decrease in working
capital requirements in the third quarter 2009 that was smaller than the
decrease in working capital requirements in the third quarter 2008.
Adjusted cash flow12 was 3,454 M€, a decrease of 39% compared
to third quarter 2008. Expressed in dollars, adjusted cash flowwas
4.9 B$, a decrease of 42%.
Net cash flow 13 for the Group was 2,089 M€ compared to
4,685 M€ in the third quarter 2008. Expressed in dollars, net cash flow
for the Group was 3.0 B$ in the third quarter 2009.
-
Results for the first nine months 2009
>
Operating income
Compared to the first nine months of 2008, the oil environment in the
first nine months of 2009 was marked by a 48% decrease in the average
price of Brent to 57.3 $/b. The TRCV European refining margin indicator
fell by 51% to 17.9 $/t. The euro-dollar exchange rate was 1.37 $/€ in
the first nine months of 2009 compared to 1.52 $/€ in the first nine
months of 2008.
In this context, the adjusted operating income from the business
segments was 10,169 M€, a decrease of 56% compared to the first nine
months of 200814. Expressed in dollars, adjusted operating
income from the business segments was 13.9 B$, a decrease of 60%
compared to the first nine months of 2008.
The effective tax rate15 for the business segments was 55% in
the first nine months of 2009 compared to 58% in the first nine months
of 2008, reflecting mainly the lower tax rate in the Upstream.
Adjusted net operating income from the business segments was 5,536 M€
compared to 11,019 M€ in the first nine months of 2008, a decrease of
50%. The smaller decrease, relative to the one in adjusted operating
income, is essentially due to the lower effective tax rate between the
two periods and a more limited decrease in the contribution from equity
affiliates.
Expressed in dollars, adjusted net operating income from the business
segments fell by 55%.
>
Net income
Adjusted net income decreased by 48% to 5,703 M€ in the first nine
months of 2009 from 11,047 M€ in the first nine months of 2008. It
excludes the after-tax inventory effect, special items, and the Group’s
equity share of adjustments and selected items related to Sanofi-Aventis.
-
The after-tax inventory effect had a positive impact on net income of
1,237 M€ in the first nine months of 2009 compared to a positive
impact of 676 M€ in the first nine months of 2008.
-
The Group’s share of adjustments and selected items related to
Sanofi-Aventis had a negative impact on net income of 252 M€ in the
first nine months of 2009. The adjustments related to Sanofi-Aventis
had a negative impact on net income of 227 M€ in the first nine months
of 2008.
-
Other special items had a negative impact on net income of 306 M€ in
the first nine months of 2009 compared to a negative impact of 112 M€
in the first nine months of 200816.
Reported net income (Group share) was 6,382 M€ compared to 11,384 M€ in
the first nine months of 2008.
The effective tax rate for the Group was 55% in the first nine months of
2009.
The Group did not buy back shares in the first nine months of 2009. On
September 30, 2009, there were 2,239.7 million fully-diluted shares
compared to 2,238.3 million fully-diluted shares on September 30, 2008.
Adjusted fully-diluted earnings per share, based on 2,235.9 million
weighted-average shares was 2.55 euros compared to 4.91 euros in the
first nine months of 2008, a decrease of 48%.
Expressed in dollars, the adjusted fully-diluted earnings per share was
3.49 compared to 7.47 in the first nine months of 2008, a decrease of
53%.
>
Investments – divestments
17
Investments excluding acquisitions and including net investments in
equity affiliates and non-consolidated companies were 9.0 B€ (12.2 B$)
in the first nine months of 2009 compared to 7.4 B€ (11.2 B$) in the
first nine months of 2008.
Acquisitions were 631 M€ in the first nine months of 2009.
Asset sales in the first nine months of 2009 were 1,842 M€, consisting
essentially of Sanofi-Aventis shares.
Net investments18 were 7.7 B€ in the first nine months of
2009, slightly higher than the 7.2 B€ in the first nine months of 2008.
Expressed in dollars, net investments in the first nine months of 2009
were 10.5 B$, a decrease of 5% compared to the 11 B$ of net investments
in the first nine months of 2008.
>
Cash flow
Cash flow from operating activities was 10,471 M€, a decrease of 28%
compared to the first nine months of 2008, essentially due to the
decrease in net income.
Adjusted cash flow19 was 10,063 M€, a decrease of 32%.
Expressed in dollars, adjusted cash flow was 13.8 B$, a decrease of 39%.
Net cash flow20 for the Group was 2,783 M€ compared to
7,336 M€ in the first nine months of 2008. Expressed in dollars, net
cash flow for the Group was 3.8 B$ in the first nine months of 2009.
The net-debt-to-equity ratio was 20.8% on September 30, 2009 compared to
24.7% on June 30, 2009 and 15.4% on September 30, 200821.
-
Analysis of business segment results
Upstream
>
Environment – liquids and gas price realizations*
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
68.1
|
|
59.1
|
|
115.1
|
|
-41%
|
|
Brent ($/b)
|
|
57.3
|
|
111.1
|
|
-48%
|
|
65.1
|
|
54.8
|
|
107.8
|
|
-40%
|
|
Average liquids price ($/b)
|
|
53.7
|
|
104.4
|
|
-49%
|
|
4.89
|
|
4.71
|
|
8.05
|
|
-39%
|
|
Average gas price ($/Mbtu)
|
|
5.20
|
|
7.31
|
|
-29%
|
|
50.7
|
|
44.2
|
|
83.9
|
|
-40%
|
|
Average hydrocarbons price ($/boe)
|
|
44.5
|
|
80.4
|
|
-45%
|
* consolidated subsidiaries, excluding fixed margin and buy-back
contracts.
Total’s average realized liquids price decreased by 40% and 49%,
respectively, in the third quarter and the first nine months of 2009
compared to the same periods in 2008, in line with the changes in the
price of Brent.
The average realized price for Total’s natural gas decreased by 39% in
the third quarter 2009 compared to the third quarter 2008 and by 29% in
the first nine months of 2009 compared to the first nine months of 2008.
>
Production
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Hydrocarbon production
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
2,243
|
|
2,182
|
|
2,231
|
|
+1%
|
|
Combined production (kboe/d)
|
|
2,249
|
|
2,336
|
|
-4%
|
|
1,379
|
|
1,328
|
|
1,409
|
|
-2%
|
|
= Liquids (kb/d)
|
|
1,373
|
|
1,463
|
|
-6%
|
|
4,726
|
|
4,686
|
|
4,471
|
|
+6%
|
|
= Gas (Mcf/d)
|
|
4,789
|
|
4,743
|
|
+1%
|
Hydrocarbon production was 2,243 thousand barrels of oil equivalent per
day (kboe/d) in the third quarter 2009, an increase of 0.5% compared to
the third quarter 2008 and 2.8% compared to the second quarter 2009.
Compared to the third quarter 2008, production increased mainly as a
result of :
-
+5% for ramp-ups and start-ups of new fields net of the normal decline,
-
+1% for the price effect22,
-
-2.5% for OPEC reductions and lower gas demand linked to the economic
recession,
-
-1% for disruptions in Nigeria related to security issues,
-
-2% for changes in the portfolio, mainly in Venezuela and Libya.
In the first nine months of 2009, hydrocarbon production was 2,249
kboe/d, a decrease of 3.7% compared to the first nine months of 2008,
mainly as a result of :
-
+1.5% for ramp-ups and start-ups of new fields net of the normal
decline,
-
+2% for the price effect22,
-
-3% for OPEC reductions and lower gas demand,
-
-1.5% for disruptions in Nigeria related to security issues
-
-2.5% for changes in the portfolio, essentially in Venezuela and Libya.
>
Results
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of euros
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
3,236
|
|
2,843
|
|
6,525
|
|
-50%
|
|
Adjusted operating income*
|
|
8,971
|
|
19,912
|
|
-55%
|
|
1,501
|
|
1,451
|
|
2,899
|
|
-48%
|
|
Adjusted net operating income*
|
|
4,434
|
|
8,729
|
|
-49%
|
|
190
|
|
176
|
|
368
|
|
-48%
|
|
-
includes income from equity affiliates
|
|
593
|
|
967
|
|
-39%
|
|
2,512
|
|
2,664
|
|
2,480
|
|
+1%
|
|
Investments
|
|
7,426
|
|
6,734
|
|
+10%
|
|
87
|
|
105
|
|
188
|
|
-54%
|
|
Divestments
|
|
321
|
|
860
|
|
-63%
|
|
2,854
|
|
1,943
|
|
3,732
|
|
-24%
|
|
Cash flow from operating activities
|
|
7,375
|
|
11,626
|
|
-37%
|
|
2,939
|
|
2,550
|
|
3,715
|
|
-21%
|
|
Adjusted cash flow
|
|
8,168
|
|
11,464
|
|
-29%
|
-
* detail of adjustment items shown in business segment information.
Adjusted net operating income for the Upstream segment was 1,501 M€ in
the third quarter 2009 compared to 2,899 M€ in the third quarter 2008, a
decrease of 48%.
Expressed in dollars, adjusted net operating income for the Upstream
segment decreased by 51%, reflecting essentially the impact of lower
hydrocarbon prices compared to the third quarter 2008.
Compared to the third quarter 2008, the decrease in income from equity
affiliates was driven principally by lower results from Nigeria LNG.
The effective tax rate for the Upstream segment was 59% compared to 58%
in the second quarter 2009 and 62% in the third quarter 2008.Over the
first nine months of 2009, adjusted net operating income for the
Upstream segment was 4,434 M€ compared to 8,729 M€ in the first nine
months of 2008, a decrease of 49%.
Expressed in dollars, adjusted net operating income for the Upstream
segment was 6.1 B$, a 54% decrease compared to the first nine months of
2008, essentially due to lower hydrocarbon prices.
The return on average capital employed (ROACE 23) for the
Upstream segment for the twelve months ended September 30, 2009 was 20%
compared to 25% for the twelve months ended June 30, 2009 and 36% for
the full year 2008.
Downstream
>
Refinery throughput and utilization rates*
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
2,142
|
|
2,175
|
|
2,393
|
|
-10%
|
|
Total refinery throughput (kb/d)
|
|
2,184
|
|
2,360
|
|
-7%
|
|
828
|
|
925
|
|
1,013
|
|
-18%
|
|
= France
|
|
882
|
|
959
|
|
-8%
|
|
1,045
|
|
1,024
|
|
1,168
|
|
-11%
|
|
= Rest of Europe
|
|
1,052
|
|
1,130
|
|
-7%
|
|
269
|
|
226
|
|
212
|
|
+27%
|
|
= Rest of world
|
|
250
|
|
271
|
|
-8%
|
|
|
|
|
|
|
|
|
Utilization rates
|
|
|
|
|
|
|
|
78%
|
|
79%
|
|
89%
|
|
|
|
= Based on crude only
|
|
79%
|
|
87%
|
|
|
|
82%
|
|
84%
|
|
92%
|
|
|
|
= Based on crude and other feedstock
|
|
84%
|
|
91%
|
|
|
* includes share of CEPSA.
In the third quarter 2009, refinery throughput decreased by 10% compared
to the third quarter 2008 and by 2% compared to the second quarter 2009.
The third quarter 2009 was affected by scheduled refinery turnarounds at
Vlissingen and Normandy. Also, during the quarter, several refineries
elected to reduce throughput to adjust to economic conditions.
Scheduled turnarounds and voluntary throughput reductions in the third
quarter 2009 reduced the utilization rate based on crude and other
feedstock to 82% from 92% in the third quarter 2008.
>
Results
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of euros except TRCV refining margins
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
6.6
|
|
12.4
|
|
45.0
|
|
-85%
|
|
European refining margin
indicator - TRCV ($/t)
|
|
17.9
|
|
36.6
|
|
-51%
|
|
83
|
|
141
|
|
1,215
|
|
-93%
|
|
Adjusted operating income*
|
|
1,015
|
|
2,457
|
|
-59%
|
|
146
|
|
156
|
|
901
|
|
-84%
|
|
Adjusted net operating income*
|
|
902
|
|
1,799
|
|
-50%
|
|
75
|
|
28
|
|
39
|
|
+92%
|
|
-
includes income from equity affiliates
|
|
136
|
|
56
|
|
x2.4
|
|
607
|
|
825
|
|
638
|
|
-5%
|
|
Investments
|
|
1,927
|
|
1,446
|
|
+33%
|
|
23
|
|
26
|
|
46
|
|
-50%
|
|
Divestments
|
|
85
|
|
198
|
|
-57%
|
|
944
|
|
(28)
|
|
2,731
|
|
-65%
|
|
Cash flow from operating activities
|
|
2,564
|
|
2,508
|
|
+2%
|
|
229
|
|
239
|
|
1,466
|
|
-84%
|
|
Adjusted cash flow
|
|
1,402
|
|
2,609
|
|
-46%
|
* detail of adjustment items shown in business segment information.
The TRCV European refining margin indicator averaged 6.6 $/t in the
third quarter 2009, a decrease of 85% compared to the third quarter
2008. For the first nine months of 2009, the TRCV European refining
margin indicator averaged 17.9 $/t, a decrease of 51% compared to the
same period last year.
Adjusted net operating income for the Downstream segment was 146 M€ in
the third quarter 2009, a decrease of 84% compared to the third quarter
2008, reflecting essentially the sharp decrease in refining margins.
Expressed in dollars, adjusted net operating income for the Downstream
segment was 209 M$, a decrease of 85% compared to the third quarter 2008.
Adjusted net operating income for the Downstream segment in the first
nine months of 2009 was 902 M€, a decrease of 50% compared to the first
nine months of 2008.
Expressed in dollars, adjusted net operating income for the Downstream
segment was 1.2 B$ in the first nine months of 2009, a decrease of 55%
compared to the first nine months of 2008, reflecting essentially the
unfavorable refining environment.
The ROACE24 for the Downstream segment for the twelve months
ended September 30, 2009 was 13% compared to 18% for the twelve months
ended June 30, 2009 and 20% for the full year 2008.
Chemicals
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of euros
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
3,892
|
|
3,684
|
|
5,431
|
|
-28%
|
|
Sales
|
|
10,794
|
|
16,138
|
|
-33%
|
|
2,326
|
|
2,164
|
|
3,675
|
|
-37%
|
|
= Base chemicals
|
|
6,266
|
|
10,727
|
|
-42%
|
|
1,566
|
|
1,520
|
|
1,756
|
|
-11%
|
|
= Specialties
|
|
4,528
|
|
5,411
|
|
-16%
|
|
191
|
|
60
|
|
343
|
|
-44%
|
|
Adjusted operating income*
|
|
183
|
|
619
|
|
-70%
|
|
161
|
|
71
|
|
263
|
|
-39%
|
|
Adjusted net operating income*
|
|
200
|
|
491
|
|
-59%
|
|
53
|
|
19
|
|
176
|
|
-70%
|
|
|
|
32
|
|
214
|
|
-85%
|
|
111
|
|
58
|
|
89
|
|
+25%
|
|
|
|
185
|
|
284
|
|
-35%
|
|
112
|
|
115
|
|
212
|
|
-47%
|
|
Investments
|
|
406
|
|
597
|
|
-32%
|
|
13
|
|
8
|
|
14
|
|
-7%
|
|
Divestments
|
|
27
|
|
33
|
|
-18%
|
|
300
|
|
280
|
|
14
|
|
x21
|
|
Cash flow from operating activities
|
|
758
|
|
(19)
|
|
na
|
|
244
|
|
114
|
|
352
|
|
-31%
|
|
Adjusted cash flow
|
|
224
|
|
770
|
|
-71%
|
* detail of adjustment items shown in business segment information.
In the third quarter 2009, the environment for the Chemicals segment
continued to be affected by weak demand in Europe and North America, but
margins for the Petrochemicals increased from the levels of the previous
quarter.
In the third quarter 2009, sales for the Chemicals segment were 3.9 B€.
Adjusted net operating income for the Chemicals segment was 161 M€ in
the third quarter 2009, a decrease of 39% compared to the third quarter
2008 but more than double the level of the second quarter 2009. The
sequential improvement reflects improved margins and lower costs in both
the Petrochemicals and the Specialties.
In the first nine months of 2009, adjusted net operating income for the
Chemicals segment was 200 M€ compared to 491 M€ for the same period in
2008, a decrease of 59% that resulted from significantly weaker demand
in Europe and North America.
The ROACE25 for the Chemicals segment for the twelve months
ended September 30, 2009 was 5% compared to 7% for the twelve months
ended June 30, 2009 and 9% for the full year 2008.
The ROACE for the twelve months ended September 30, 2009 was 15% for the
Group and 16% for the business segments. The ROACE at the Group level
was 19% for the twelve months ended June 30, 2009 and 26% for the full
year 2008.Return on equity for the twelve months ended September 30,
2009 was 17.5%.
Investments26 in the business segments, excluding
acquisitions, were 12.2 B$ through September 2009, in line with the 2009
budget of 18 B$ for the full year. The net-debt-to-equity-ratio was
20.8% at September 30, 2009 compared to 24.7% at the end of the previous
quarter.
Following the July 30, 2009 approval by the Board of Directors, Total
will pay the 2009 interim dividend of 1.14 € per share on November 18,
200927.
Since the start of the fourth quarter 2009, the dollar has continued to
fall against the euro, while oil prices have continued to rise, lifted
by expectations for an economic recovery, the onset of the winter
heating season in the northern hemisphere and the perception of a tight
supply-demand balance in the medium term.
Despite modest improvement in diesel margins, European refining margins
remain at very weak levels, requiring the Group to maintain voluntary
throughput reductions.
In the Upstream, with the start-up of Yemen LNG in mid-October, the
Group’s production in the coming months should reflect the ongoing
ramp-up from the major projects started up in 2009 and maintenance
levels normally below that of the third quarter.
To provide for production growth over the medium term, Total is
continuing to prepare its next wave of projects, including Surmont Phase
2 in Canada, CLOV in Angola and Laggan-Tormore in the UK, for which it
expects to make final investment decisions in the coming quarters.
To listen to CFO Patrick de la Chevardière’s conference call with
financial analysts today at 15:00 (Paris time) please log on to
www.total.com
or call +44 (0)203 367 9453 in Europe or +1 866 907 5928 in the U.S.
(access code : Total). For a replay through November 12, please consult
the website or call +44 (0)207 107 0686 in Europe or 1 877 642 3018
in the US (code : 264 973).
The September 30, 2009 notes to the condensed consolidated accounts
are available on the Total web site (
www.total.com
).
This document may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 with respect to
the financial condition, results of operations, business, strategy and
plans of Total. Such statements are based on a number of assumptions
that could ultimately prove inaccurate, and are subject to a number of
risk factors, including currency fluctuations, the price of petroleum
products, the ability to realize cost reductions and operating
efficiencies without unduly disrupting business operations,
environmental regulatory considerations and general economic and
business conditions. Total does not assume any obligation to update
publicly any forward-looking statement, whether as a result of new
information, future events or otherwise. Further information on factors
which could affect the company’s financial results is provided in
documents filed by the Group and its affiliates with the French Autorité
des Marchés Financiers and the US Securities and Exchange Commission.
Business segment information is presented in accordance with the
Group internal reporting system used by the Chief operating decision
maker to measure performance and allocate resources internally. Due to
their particular nature or significance, certain transactions qualified
as “special items” are excluded from the business segment figures. In
general, special items relate to transactions that are significant,
infrequent or unusual. However, in certain instances, certain
transactions such as restructuring costs or assets disposals, which are
not considered to be representative of normal course of business, may be
qualified as special items although they may have occurred within prior
years or are likely to recur within following years.
The adjusted results of the Downstream and Chemical segments are also
presented according to the replacement cost method. This method is used
to assess the segments’ performance and ensure the comparability of the
segments’ results with those of its competitors, mainly North American.
In the replacement cost method, which approximates the LIFO (Last-In,
First-Out) method, the variation of inventory values in the income
statement is determined by the average price of the period rather than
the historical value. The inventory valuation effect is the difference
between the results according to FIFO (First-In, First-Out) and
replacement cost.
In this framework, performance measures such as adjusted operating
income, adjusted net operating income and adjusted net income are
defined as incomes using replacement cost, adjusted for special items
and excluding Total’s equity share of the adjustments and, from 2009,
selected items related to Sanofi-Aventis. They are meant to facilitate
the analysis of the financial performance and the comparison of income
between periods.
Dollar amounts presented herein represent euro amounts converted at
the average euro-dollar exchange rate for the applicable period and are
not the result of financial statements prepared in dollars.
Operating information by segmentThird quarter and first nine months
2009
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Combined liquids and gas production by region (kboe/d)
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
569
|
|
574
|
|
553
|
|
+3%
|
|
Europe
|
|
609
|
|
593
|
|
+3%
|
|
762
|
|
713
|
|
747*
|
|
+2%
|
|
Africa
|
|
739
|
|
795*
|
|
-7%
|
|
31
|
|
13
|
|
13
|
|
x2.4
|
|
North America
|
|
18
|
|
14
|
|
+29%
|
|
259
|
|
248
|
|
247
|
|
+5%
|
|
Far East
|
|
254
|
|
248
|
|
+2%
|
|
419
|
|
420
|
|
430
|
|
-3%
|
|
Middle East
|
|
419
|
|
433
|
|
-3%
|
|
183
|
|
193
|
|
218*
|
|
-16%
|
|
South America
|
|
187
|
|
227*
|
|
-18%
|
|
20
|
|
21
|
|
23
|
|
-13%
|
|
Rest of world
|
|
23
|
|
26
|
|
-12%
|
|
2,243
|
|
2,182
|
|
2,231
|
|
+1%
|
|
Total production
|
|
2,249
|
|
2,336
|
|
-4%
|
|
351
|
|
342
|
|
398
|
|
-12%
|
|
Includes equity and non-consolidated affiliates
|
|
348
|
|
404
|
|
-14%
|
* restated to reclassify Total’s 48.83% share of CEPSA’s production
in Colombia.
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Liquids production by region (kb/d)
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
279
|
|
275
|
|
288
|
|
-3%
|
|
Europe
|
|
291
|
|
295
|
|
-1%
|
|
647
|
|
600
|
|
627*
|
|
+3%
|
|
Africa
|
|
627
|
|
666*
|
|
-6%
|
|
27
|
|
11
|
|
10
|
|
x2.7
|
|
North America
|
|
16
|
|
11
|
|
+45%
|
|
33
|
|
33
|
|
28
|
|
+18%
|
|
Far East
|
|
34
|
|
28
|
|
+21%
|
|
300
|
|
310
|
|
330
|
|
-9%
|
|
Middle East
|
|
308
|
|
332
|
|
-7%
|
|
79
|
|
87
|
|
115*
|
|
-31%
|
|
South America
|
|
84
|
|
119*
|
|
-29%
|
|
14
|
|
12
|
|
11
|
|
+27%
|
|
Rest of world
|
|
13
|
|
12
|
|
+8%
|
|
1,379
|
|
1,328
|
|
1,409
|
|
-2%
|
|
Total production
|
|
1,373
|
|
1,463
|
|
-6%
|
|
286
|
|
289
|
|
344
|
|
-17%
|
|
Includes equity and non-consolidated affiliates
|
|
289
|
|
350
|
|
-17%
|
* restated to reclassify Total’s 48.83% share of CEPSA’s production
in Colombia.
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Gas production by region (Mcf/d)
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
1,580
|
|
1,639
|
|
1,442
|
|
+10%
|
|
Europe
|
|
1,733
|
|
1,618
|
|
+7%
|
|
583
|
|
580
|
|
621
|
|
-6%
|
|
Africa
|
|
572
|
|
659
|
|
-13%
|
|
19
|
|
9
|
|
12
|
|
+58%
|
|
North America
|
|
12
|
|
18
|
|
-33%
|
|
1,276
|
|
1,215
|
|
1,210
|
|
+5%
|
|
Far East
|
|
1,238
|
|
1,222
|
|
+1%
|
|
657
|
|
609
|
|
552
|
|
+19%
|
|
Middle East
|
|
614
|
|
560
|
|
+10%
|
|
575
|
|
585
|
|
569
|
|
+1%
|
|
South America
|
|
570
|
|
589
|
|
-3%
|
|
36
|
|
49
|
|
65
|
|
-45%
|
|
Rest of world
|
|
50
|
|
77
|
|
-35%
|
|
4,726
|
|
4,686
|
|
4,471
|
|
+6%
|
|
Total production
|
|
4,789
|
|
4,743
|
|
+1%
|
|
355
|
|
285
|
|
290
|
|
+22%
|
|
Includes equity and non-consolidated affiliates
|
|
314
|
|
293
|
|
+7%
|
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Liquefied natural gas
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
2.12
|
|
2.12
|
|
2.32
|
|
-9%
|
|
LNG sales* (Mt)
|
|
6.34
|
|
6.90
|
|
-8%
|
* sales, Group share, excluding trading ; 1 Mt/y = approx. 133 Mcf/d
; data from 2008 previous period have been restated to reflect volumes
estimation for Bontang LNG in Indonesia based on the 2008 SEC
coefficient.
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
Refined products sales by region (kb/d)*
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
2,014
|
|
1,979
|
|
2,161
|
|
-7%
|
|
Europe
|
|
2,055
|
|
2,102
|
|
-2%
|
|
278
|
|
272
|
|
279
|
|
-
|
|
Africa
|
|
276
|
|
279
|
|
-1%
|
|
164
|
|
161
|
|
136
|
|
+21%
|
|
Americas
|
|
171
|
|
170
|
|
+1%
|
|
134
|
|
148
|
|
147
|
|
-9%
|
|
Rest of world
|
|
137
|
|
145
|
|
-6%
|
|
2,590
|
|
2,560
|
|
2,723
|
|
-5%
|
|
Total consolidated sales
|
|
2,639
|
|
2,696
|
|
-2%
|
|
887
|
|
1,092
|
|
992
|
|
-11%
|
|
Trading
|
|
993
|
|
964
|
|
+3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,477
|
|
3,652
|
|
3,715
|
|
-6%
|
|
Total refined product sales
|
|
3,632
|
|
3,660
|
|
-1%
|
* includes share of CEPSA
Adjustment items
-
Adjustments to operating income from business segments
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
in millions of euros
|
|
9M09
|
|
9M08
|
|
(9)
|
|
(188)
|
|
-
|
|
Special items affecting operating income from the business segments
|
|
(300)
|
|
-
|
|
-
|
|
-
|
|
-
|
|
|
|
-
|
|
-
|
|
(3)
|
|
(105)
|
|
-
|
|
|
|
(108)
|
|
-
|
|
(6)
|
|
(83)
|
|
-
|
|
|
|
(192)
|
|
-
|
|
214
|
|
1,065
|
|
(1,193)
|
|
Pre-tax inventory effect : FIFO vs. replacement cost
|
|
1,756
|
|
869
|
|
|
|
|
|
|
|
|
|
|
|
|
|
205
|
|
877
|
|
(1,193)
|
|
Total adjustments affecting operating income from the business
segments
|
|
1,456
|
|
869
|
-
Adjustments to net income (Group share)
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
in millions of euros
|
|
9M09
|
|
9M08
|
|
2
|
|
(221)
|
|
(190)
|
|
Special items affecting net income (Group share)
|
|
(306)
|
|
(112)
|
|
46
|
|
28
|
|
50
|
|
|
|
87
|
|
197
|
|
(7)
|
|
(99)
|
|
(4)
|
|
|
|
(112)
|
|
(48)
|
|
(2)
|
|
(71)
|
|
(34)
|
|
|
|
(73)
|
|
(34)
|
|
(35)
|
|
(79)
|
|
(202)
|
|
|
|
(208)
|
|
(227)
|
|
(70)
|
|
(119)
|
|
(78)
|
|
Equity shares of adjustments and, from 2009, selected items related
to Sanofi-Aventis*
|
|
(252)
|
|
(227)
|
|
122
|
|
788
|
|
(752)
|
|
After-tax inventory effect : FIFO vs. replacement cost
|
|
1,237
|
|
676
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54
|
|
448
|
|
(1,020)
|
|
Total adjustments to net income
|
|
679
|
|
337
|
* based on Total’s share in Sanofi-Aventis of 8.6% at 9/30/2009, 9.7%
at 6/30/2009, and 12.4% at 9/30/2008.
Effective tax rates
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
Effective tax rate*
|
|
9M09
|
|
9M08
|
|
59.3%
|
|
58.3%
|
|
61.7%
|
|
Upstream
|
|
58.6%
|
|
61.8%
|
|
56.5%
|
|
55.9%
|
|
55.9%
|
|
Group
|
|
54.8%
|
|
57.6%
|
* tax on adjusted net operating income / (adjusted net operating
income - income from equity affiliates, dividends received from
investments, and impairments of acquisition goodwill + tax on adjusted
net operating income).
Investments - Divestments
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
in millions of euros
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
3,111
|
|
3,095
|
|
2,774
|
|
+12%
|
|
Investments excluding acquisitions
*
|
|
8,953
|
|
7,363
|
|
+22%
|
|
227
|
|
154
|
|
212
|
|
+7%
|
|
|
|
609
|
|
589
|
|
+3%
|
|
187
|
|
23
|
|
(56)
|
|
na
|
|
-
Net investments in equity affiliates and non-consolidated
companies
|
|
435
|
|
(466)
|
|
na
|
|
58
|
|
480
|
|
421
|
|
-86%
|
|
Acquisitions
|
|
631
|
|
516
|
|
+22%
|
|
3,169
|
|
3,575
|
|
3,195
|
|
-1%
|
|
Investments including acquisitions
*
|
|
9,584
|
|
7,879
|
|
+22%
|
|
702
|
|
781
|
|
524
|
|
+34%
|
|
Asset sales
|
|
1,842
|
|
719
|
|
x2.6
|
|
2,449
|
|
2,776
|
|
2,653
|
|
-8%
|
|
Net investments **
|
|
7,688
|
|
7,240
|
|
+6%
|
|
3Q09
|
|
2Q09
|
|
3Q08
|
|
3Q09 vs 3Q08
|
|
expressed in millions of dollars***
|
|
9M09
|
|
9M08
|
|
9M09 vs 9M08
|
|
4,450
|
|
4,219
|
|
4,175
|
|
+7%
|
|
Investments excluding acquisitions
*
|
|
12,234
|
|
11,204
|
|
+9%
|
|
325
|
|
210
|
|
319
|
|
+2%
|
|
|
|
832
|
|
896
|
|
-7%
|
|
267
|
|
31
|
|
(84)
|
|
na
|
|
-
Net investments in equity affiliates and non-consolidated
companies
|
|
594
|
|
(709)
|
|
na
|
|
83
|
|
654
|
|
634
|
|
-87%
|
|
Acquisitions
|
|
862
|
|
785
|
|
+10%
|
|
4,533
|
|
4,873
|
|
4,809
|
|
-6%
|
|
Investments including acquisitions
*
|
|
13,097
|
|
11,989
|
|
+9%
|
|
1,004
|
|
1,065
|
|
789
|
|
+27%
|
|
Asset sales
|
|
2,517
|
|
1,094
|
|
x2.3
|
|
3,503
|
|
3,784
|
|
3,993
|
|
-12%
|
|
Net investments **
|
|
10,506
|
|
11,017
|
|
-5%
|
* includes net investments in equity affiliates and non-consolidated
companies.** net investments = investments including acquisitions and
net investments in equity affiliates and non-consolidated companies –
asset sales + net financing for employees related to stock purchase
plans.*** dollar amounts represent euro amounts converted at the average
€-$ exchange rate for the period
Net-debt-to-equity ratio
|
in millions of euros
|
|
9/30/2009
|
|
6/30/2009
|
|
9/30/2008
|
|
Current borrowings
|
|
6,012
|
|
7,916
|
|
5,378
|
|
Net current financial assets
|
|
(160)
|
|
(123)
|
|
(230)
|
|
Non-current financial debt
|
|
19,146
|
|
19,640
|
|
16,347
|
|
Hedging instruments of non-current debt
|
|
(983)
|
|
(875)
|
|
(406)
|
|
Cash and cash equivalents
|
|
(13,775)
|
|
(14,299)
|
|
(13,231)
|
|
Net debt
|
|
10,240
|
|
12,259
|
|
7,858
|
|
|
|
|
|
|
|
|
|
Shareholders equity
|
|
49,620
|
|
51,299
|
|
50,801
|
|
Estimated dividend payable*
|
|
(1,273)
|
|
(2,541)
|
|
(920)
|
|
Minority interests
|
|
959
|
|
963
|
|
1,001
|
|
Equity
|
|
49,306
|
|
49,721
|
|
50,882
|
|
|
|
|
|
|
|
|
|
Net-debt-to-equity ratio
|
|
20.8%
|
|
24.7%
|
|
15.4%
|
* for 9/30/09, based on a 2009 dividend equal to the dividend paid in
2008 (2.28 €/share), after deducting the interim dividend of 1.14 € per
share approved by the Board of Directors on July 30, 2009.
2009 Sensitivities*
|
|
|
Scenario
|
|
Change
|
|
Impact on adjusted operating income(e)
|
|
Impact on adjusted net operating income(e)
|
|
Dollar
|
|
1.30 $/€
|
|
+0.1 $ per €
|
|
-1.3 B€
|
|
-0.7 B€
|
|
Brent
|
|
60 $/b
|
|
+1 $/b
|
|
+0.32 B€ / 0.42 B$
|
|
+0.15 B€ / 0.20 B$
|
|
European refining margins TRCV
|
|
30 $/t
|
|
+1 $/t
|
|
+0.08 B€ / 0.11 B$
|
|
+0.06 B€ / 0.07 B$
|
* sensitivities revised once per year upon publication of the
previous year’s fourth quarter results. The impact of the €-$
sensitivity on adjusted operating income and adjusted net operating
income attributable to the Upstream segment are approximately 75% and
65% respectively, and the remaining impact of the €-$ sensitivity is
essentially in the Downstream segment.
Return on average capital employed
-
For the twelve months ended September 30, 2009
|
in millions of euros
|
|
Upstream
|
|
Downstream
|
|
Chemicals**
|
|
Segments
|
|
Group***
|
|
Adjusted net operating income
|
|
6,429
|
|
1,672
|
|
377
|
|
8,478
|
|
9,096
|
|
Capital employed at 9/30/2008*
|
|
30,184
|
|
12,649
|
|
8,107
|
|
50,940
|
|
58,165
|
|
Capital employed at 9/30/2009*
|
|
35,514
|
|
13,513
|
|
6,845
|
|
55,872
|
|
61,030
|
|
ROACE
|
|
19.6%
|
|
12.8%
|
|
5.0%
|
|
15.9%
|
|
15.3%
|
* at replacement cost (excluding after-tax inventory effect).**
capital employed for Chemicals reduced for the Toulouse-AZF provision of
121 M€ pre-tax at 9/30/2008*** capital employed for the Group adjusted
for the amount of the interim dividend payable approved in July 2009
(2,544 M€).
-
For the twelve months ended June 30, 2009
|
in millions of euros
|
|
Upstream
|
|
Downstream
|
|
Chemicals**
|
|
Segments
|
|
Group
|
|
Adjusted net operating income
|
|
7,827
|
|
2,427
|
|
479
|
|
10,733
|
|
11,388
|
|
Capital employed at 6/30/2008*
|
|
26,676
|
|
13,491
|
|
7,394
|
|
47,561
|
|
56,107
|
|
Capital employed at 6/30/2009*
|
|
35,385
|
|
13,939
|
|
6,915
|
|
56,239
|
|
62,294
|
|
ROACE
|
|
25.2%
|
|
17.7%
|
|
6.7%
|
|
20.7%
|
|
19.2%
|
* at replacement cost (excluding after-tax inventory effect).**
capital employed for Chemicals reduced for the Toulouse-AZF provision of
126 M€ pre-tax at 6/30/2008.
-
For the twelve months ended September 30, 2008
|
in millions of euros
|
|
Upstream
|
|
Downstream
|
|
Chemicals**
|
|
Segments
|
|
Group***
|
|
Adjusted net operating income
|
|
11,298
|
|
2,345
|
|
578
|
|
14,221
|
|
14,915
|
|
Capital employed at 9/30/2007*
|
|
26,863
|
|
11,446
|
|
7,305
|
|
45,614
|
|
53,243
|
|
Capital employed at 9/30/2008*
|
|
30,184
|
|
12,649
|
|
8,107
|
|
50,940
|
|
58,165
|
|
ROACE
|
|
39.6%
|
|
19.5%
|
|
7.5%
|
|
29.5%
|
|
26.8%
|
* at replacement cost (excluding after-tax inventory effect).**
capital employed for Chemicals reduced for the Toulouse-AZF provision of
139 M€ pre-tax at 9/30/2007 and 121 M€ pre-tax at 9/30/2008.*** capital
employed for the Group adjusted for the amount of the interim dividend
payable approved in September 2008 (2,545 M€).
1 percent changes are relative to the same period 2008.
2 dollar amounts represent euro amounts converted at the
average €-$ exchange rate for the period : 1.4303 $/€ in the 3
rd
quarter 2009, 1.5050 $/€ in the 3
rd
quarter 2008,
1.3632 $/€ in the 2
nd
quarter 2009, 1.3665 $/€ for the
first nine months of 2009 and 1.5217 $/€ for the first nine months of
2008.
3 adjusted net income = net income using replacement cost
(Group share) adjusted for special items and excluding Total’s share of
adjustments and, from 2009, selected items related to Sanofi-Aventis.
Total’s net income (Group share) for the 3nd quarter 2009 was
1,923 M€.
4 adjusted income (adjusted operating income, adjusted net
operating income and adjusted net income) is defined as income using
replacement cost, adjusted for special items affecting operating income
and excluding Total’s equity share of adjustments and, from 2009,
selected items related to Sanofi-Aventis; adjusted cash flow from
operations is defined as cash flow from operations before changes in
working capital at replacement cost; adjustment items are on page 17.
5 including acquisitions.
6 dollar amounts represent euro amounts converted at the
average €-$ exchange rate for the period.
7 special items affecting operating income from the business
segments had a negative impact of 9 M€ in the 3rd quarter
2009 and no impact in the 3rd quarter 2008.
8 defined as: (tax on adjusted net operating income) /
(adjusted net operating income – income from equity affiliates,
dividends received from investments and impairments of acquisition
goodwill + tax on adjusted net operating income).
9 detail shown on page 17.
10 detail shown on page 18.
11 net investments = investments including acquisitions and
net investments in equity affiliates and non-consolidated companies –
asset sales + net financing for employees related to stock purchase
plans.
12 cash flow from operations at replacement cost before
changes in working capital.
13 net cash flow = cash flow from operations + divestments –
gross investments.
14 special items affecting operating income from the business
segments had a negative impact of 300 M€ in the first nine months of
2009 and no impact in the first nine months of 2008.
15 defined as: (tax on adjusted net operating income) /
(adjusted net operating income – income from equity affiliates,
dividends received from investments and impairments of acquisition
goodwill + tax on adjusted net operating income).
16 detail shown on page 17.
17 detail shown on page 18.
18 net investments = investments including acquisitions and
net investments in equity affiliates and non-consolidated companies –
asset sales + net financing for employees related to stock purchase
plans.
19 cash flow from operations at replacement cost before
changes in working capital.
20 net cash flow = cash flow from operations + divestments –
gross investments.
21 detail shown on page 19.
22 impact of changing hydrocarbon prices on entitlement
volumes.
23 calculated based on adjusted net operating income and
average capital employed, using replacement cost, as shown on page 20.
24 calculated based on adjusted net operating income and
average capital employed, using replacement cost, as shown on page 20.
25 calculated based on adjusted net operating income and
average capital employed, using replacement cost, as shown on page 20.
26 includes net investments in equity affiliates and
non-consolidated companies.
27 the ex-dividend date for the 2009 interim dividend is
November 13 and the payment date is November 18, 2009; for the ADR
(NYSE :TOT) the ex-dividend date is November 9.
Total Financial Statements
Third quarter and first nine months of 2009 consolidated accounts,
IFRS
|
CONSOLIDATED STATEMENT OF INCOME
|
|
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(M€)(a)
|
|
3
rd
quarter
2009
|
|
2
nd
quarter
2009
|
|
3
rd
quarter
2008
|
|
Sales
|
|
33,628
|
|
31,430
|
|
48,849
|
|
Excise taxes
|
|
(4,812)
|
|
(4,856)
|
|
(4,810)
|
|
Revenues from sales
|
|
28,816
|
|
26,574
|
|
44,039
|
|
Purchases, net of inventory variation
|
|
(18,940)
|
|
(16,300)
|
|
(31,054)
|
|
Other operating expenses
|
|
(4,508)
|
|
(4,724)
|
|
(4,708)
|
|
Exploration costs
|
|
(130)
|
|
(155)
|
|
(144)
|
|
Depreciation, depletion and amortization of tangible assets and
mineral interests
|
|
(1,599)
|
|
(1,636)
|
|
(1,329)
|
|
Other income
|
|
70
|
|
106
|
|
107
|
|
Other expense
|
|
(95)
|
|
(216)
|
|
(262)
|
|
Financial interest on debt
|
|
(108)
|
|
(140)
|
|
(241)
|
|
Financial income from marketable securities & cash equivalents
|
|
21
|
|
40
|
|
114
|
|
Cost of net debt
|
|
(87)
|
|
(100)
|
|
(127)
|
|
Other financial income
|
|
67
|
|
240
|
|
140
|
|
Other financial expense
|
|
(90)
|
|
(82)
|
|
(79)
|
|
Equity in income (loss) of affiliates
|
|
398
|
|
393
|
|
606
|
|
Income taxes
|
|
(1,927)
|
|
(1,877)
|
|
(4,038)
|
|
Consolidated net income
|
|
1,975
|
|
2,223
|
|
3,151
|
|
Group share*
|
|
1,923
|
|
2,169
|
|
3,050
|
|
Minority interests
|
|
52
|
|
54
|
|
101
|
|
Earnings per share (€)
|
|
0.86
|
|
0.97
|
|
1.36
|
|
Fully-diluted earnings per share (€)**
|
|
0.86
|
|
0.97
|
|
1.36
|
|
|
|
|
|
|
|
|
|
* Adjusted net income
|
|
1,869
|
|
1,721
|
|
4,070
|
|
** Adjusted fully-diluted earnings per share (€)
|
|
0.84
|
|
0.77
|
|
1.81
|
|
(a) Except for per share amounts.
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF INCOME
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
(M€) (a)
|
|
9 months
2009
|
|
9 months
2008
|
|
Sales
|
|
95,099
|
|
141,262
|
|
Excise taxes
|
|
(14,241)
|
|
(14,636)
|
|
Revenues from sales
|
|
80,858
|
|
126,626
|
|
Purchases, net of inventory variation
|
|
(50,468)
|
|
(84,631)
|
|
Other operating expenses
|
|
(13,907)
|
|
(13,979)
|
|
Exploration costs
|
|
(461)
|
|
(537)
|
|
Depreciation, depletion and amortization of tangible assets and
mineral interests
|
|
(4,755)
|
|
(4,007)
|
|
Other income
|
|
191
|
|
275
|
|
Other expense
|
|
(398)
|
|
(431)
|
|
Financial interest on debt
|
|
(419)
|
|
(702)
|
|
Financial income from marketable securities & cash equivalents
|
|
116
|
|
356
|
|
Cost of net debt
|
|
(303)
|
|
(346)
|
|
Other financial income
|
|
466
|
|
485
|
|
Other financial expense
|
|
(253)
|
|
(230)
|
|
Equity in income (loss) of affiliates
|
|
1,258
|
|
1,690
|
|
Income taxes
|
|
(5,706)
|
|
(13,186)
|
|
Consolidated net income
|
|
6,522
|
|
11,729
|
|
Group share*
|
|
6,382
|
|
11,384
|
|
Minority interests
|
|
140
|
|
345
|
|
Earnings per share (€)
|
|
2.86
|
|
5.09
|
|
Fully-diluted earnings per share (€)**
|
|
2.85
|
|
5.06
|
|
|
|
|
|
|
|
* Adjusted net income
|
|
5,703
|
|
11,047
|
|
** Adjusted fully-diluted earnings per share (€)
|
|
2.55
|
|
4.91
|
|
(a) Except for per share amounts.
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEET
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(M€)
|
|
September 30, 2009
(unaudited)
|
|
June 30, 2009
(unaudited)
|
|
December 31, 2008
|
|
September 30, 2008
(unaudited)
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
|
|
|
|
|
Intangible assets, net
|
|
5,845
|
|
5,955
|
|
5,341
|
|
5,099
|
|
Property, plant and equipment, net
|
|
49,292
|
|
48,762
|
|
46,142
|
|
45,001
|
|
Equity affiliates : investments and loans
|
|
13,685
|
|
14,075
|
|
14,668
|
|
15,175
|
|
Other investments
|
|
1,187
|
|
1,211
|
|
1,165
|
|
1,293
|
|
Hedging instruments of non-current financial debt
|
|
983
|
|
875
|
|
892
|
|
406
|
|
Other non-current assets
|
|
3,179
|
|
3,095
|
|
3,044
|
|
2,196
|
|
Total non-current assets
|
|
74,171
|
|
73,973
|
|
71,252
|
|
69,170
|
|
Current assets
|
|
|
|
|
|
|
|
|
|
Inventories, net
|
|
12,002
|
|
11,749
|
|
9,621
|
|
15,500
|
|
Accounts receivable, net
|
|
14,198
|
|
15,226
|
|
15,287
|
|
19,983
|
|
Other current assets
|
|
8,141
|
|
9,253
|
|
9,642
|
|
9,061
|
|
Current financial assets
|
|
329
|
|
217
|
|
187
|
|
293
|
|
Cash and cash equivalents
|
|
13,775
|
|
14,299
|
|
12,321
|
|
13,231
|
|
Total current assets
|
|
48,445
|
|
50,744
|
|
47,058
|
|
58,068
|
|
Total assets
|
|
122,616
|
|
124,717
|
|
118,310
|
|
127,238
|
|
LIABILITIES & SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
Shareholders' equity
|
|
|
|
|
|
|
|
|
|
Common shares
|
|
5,869
|
|
5,931
|
|
5,930
|
|
5,929
|
|
Paid-in surplus and retained earnings
|
|
53,136
|
|
55,031
|
|
52,947
|
|
53,800
|
|
Currency translation adjustment
|
|
(5,744)
|
|
(4,656)
|
|
(4,876)
|
|
(4,063)
|
|
Treasury shares
|
|
(3,641)
|
|
(5,007)
|
|
(5,009)
|
|
(4,865)
|
|
Total shareholders' equity - Group Share
|
|
49,620
|
|
51,299
|
|
48,992
|
|
50,801
|
|
Minority interests
|
|
959
|
|
963
|
|
958
|
|
1,001
|
|
Total shareholders' equity
|
|
50,579
|
|
52,262
|
|
49,950
|
|
51,802
|
|
Non-current liabilities
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
8,894
|
|
8,561
|
|
7,973
|
|
8,275
|
|
Employee benefits
|
|
2,013
|
|
2,006
|
|
2,011
|
|
2,580
|
|
Provisions and other non-current liabilities
|
|
7,936
|
|
8,087
|
|
7,858
|
|
6,857
|
|
Total non-current liabilities
|
|
18,843
|
|
18,654
|
|
17,842
|
|
17,712
|
|
Non-current financial debt
|
|
19,146
|
|
19,640
|
|
16,191
|
|
16,347
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
13,916
|
|
14,036
|
|
14,815
|
|
17,390
|
|
Other creditors and accrued liabilities
|
|
13,951
|
|
12,115
|
|
11,632
|
|
18,546
|
|
Current borrowings
|
|
6,012
|
|
7,916
|
|
7,722
|
|
5,378
|
|
Other current financial liabilities
|
|
169
|
|
94
|
|
158
|
|
63
|
|
Total current liabilities
|
|
34,048
|
|
34,161
|
|
34,327
|
|
41,377
|
|
Total Liabilities and shareholders' equity
|
|
122,616
|
|
124,717
|
|
118,310
|
|
127,238
|
|
CONSOLIDATED STATEMENT OF CASH FLOW
|
|
|
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(M€)
|
|
3
rd
quarter
2009
|
|
2
nd
quarter
2009
|
|
3
rd
quarter
2008
|
|
|
CASH FLOW FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
Consolidated net income
|
|
1,975
|
|
2,223
|
|
3,151
|
|
|
Depreciation, depletion and amortization
|
|
1,673
|
|
1,712
|
|
1,457
|
|
|
Non-current liabilities, valuation allowances and deferred taxes
|
|
310
|
|
281
|
|
242
|
|
|
Impact of coverage of pension benefit plans
|
|
-
|
|
-
|
|
-
|
|
|
(Gains) losses on sales of assets
|
|
(50)
|
|
(31)
|
|
(61)
|
|
|
Undistributed affiliates' equity earnings
|
|
(232)
|
|
81
|
|
(376)
|
|
|
(Increase) decrease in working capital
|
|
870
|
|
(2,363)
|
|
2,889
|
|
|
Other changes, net
|
|
(8)
|
|
36
|
|
36
|
|
|
Cash flow from operating activities
|
|
4,538
|
|
1,939
|
|
7,338
|
|
|
CASH FLOW USED IN INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Intangible assets and property, plant and equipment additions
|
|
(2,849)
|
|
(3,312)
|
|
(2,928)
|
|
|
Acquisitions of subsidiaries, net of cash acquired
|
|
-
|
|
(109)
|
|
(191)
|
|
|
Investments in equity affiliates and other securities
|
|
(133)
|
|
(131)
|
|
(132)
|
|
|
Increase in non-current loans
|
|
(274)
|
|
(82)
|
|
(120)
|
|
|
Total expenditures
|
|
(3,256)
|
|
(3,634)
|
|
(3,371)
|
|
|
Proceeds from disposal of intangible assets and property, plant and
equipment
|
|
4
|
|
55
|
|
35
|
|
|
Proceeds from disposal of subsidiaries, net of cash sold
|
|
-
|
|
-
|
|
4
|
|
|
Proceeds from disposal of non-current investments
|
|
698
|
|
726
|
|
485
|
|
|
Repayment of non-current loans
|
|
105
|
|
77
|
|
194
|
|
|
Total divestments
|
|
807
|
|
858
|
|
718
|
|
|
Cash flow used in investing activities
|
|
(2,449)
|
|
(2,776)
|
|
(2,653)
|
|
|
CASH FLOW (FROM)/USED FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Issuance (repayment) of shares:
|
|
|
|
|
|
|
|
|
- Parent company shareholders
|
|
5
|
|
5
|
|
16
|
|
|
- Treasury shares
|
|
1
|
|
2
|
|
(334)
|
|
|
- Minority shareholders
|
|
-
|
|
-
|
|
(1)
|
|
|
Cash dividends paid:
|
|
|
|
|
|
|
|
|
- Parent company shareholders
|
|
-
|
|
(2,541)
|
|
-
|
|
|
- Minority shareholders
|
|
15
|
|
(141)
|
|
1
|
|
|
Net issuance (repayment) of non-current debt
|
|
(617)
|
|
2,010
|
|
1,379
|
|
|
Increase (decrease) in current borrowings
|
|
(1,948)
|
|
2,350
|
|
25
|
|
|
Increase (decrease) in current financial assets and liabilities
|
|
-
|
|
-
|
|
4
|
|
|
Cash flow (from) / used in financing activities
|
|
(2,544)
|
|
1,685
|
|
1,090
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
(455)
|
|
848
|
|
5,775
|
|
|
Effect of exchange rates
|
|
(69)
|
|
132
|
|
211
|
|
|
Cash and cash equivalents at the beginning of the period
|
|
14,299
|
|
13,319
|
|
7,245
|
|
|
Cash and cash equivalents at the end of the period
|
|
13,775
|
|
14,299
|
|
13,231
|
|
|
CONSOLIDATED STATEMENT OF CASH FLOW
|
|
|
|
|
|
TOTAL
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
(M€)
|
|
9 months
2009
|
|
9 months
2008
|
|
CASH FLOW FROM OPERATING ACTIVITIES
|
|
|
|
|
|
Consolidated net income
|
|
6,522
|
|
11,729
|
|
Depreciation, depletion and amortization
|
|
5,046
|
|
4,344
|
|
Non-current liabilities, valuation allowances and deferred taxes
|
|
523
|
|
285
|
|
Impact of coverage of pension benefit plans
|
|
-
|
|
-
|
|
(Gains) losses on sales of assets
|
|
(96)
|
|
(229)
|
|
Undistributed affiliates' equity earnings
|
|
(230)
|
|
(574)
|
|
(Increase) decrease in working capital
|
|
(1,348)
|
|
(1,064)
|
|
Other changes, net
|
|
54
|
|
85
|
|
Cash flow from operating activities
|
|
10,471
|
|
14,576
|
|
CASH FLOW USED IN INVESTING ACTIVITIES
|
|
|
|
|
|
Intangible assets and property, plant and equipment additions
|
|
(8,645)
|
|
(7,874)
|
|
Acquisitions of subsidiaries, net of cash acquired
|
|
(156)
|
|
(191)
|
|
Investments in equity affiliates and other securities
|
|
(348)
|
|
(280)
|
|
Increase in non-current loans
|
|
(676)
|
|
(537)
|
|
Total expenditures
|
|
(9,825)
|
|
(8,882)
|
|
Proceeds from disposal of intangible assets and property, plant and
equipment
|
|
119
|
|
57
|
|
Proceeds from disposal of subsidiaries, net of cash sold
|
|
-
|
|
88
|
|
Proceeds from disposal of non-current investments
|
|
1,723
|
|
574
|
|
Repayment of non-current loans
|
|
295
|
|
923
|
|
Total divestments
|
|
2,137
|
|
1,642
|
|
Cash flow used in investing activities
|
|
(7,688)
|
|
(7,240)
|
|
CASH FLOW (FROM)/USED FINANCING ACTIVITIES
|
|
|
|
|
|
Issuance (repayment) of shares:
|
|
|
|
|
|
- Parent company shareholders
|
|
19
|
|
258
|
|
- Treasury shares
|
|
3
|
|
(1,045)
|
|
- Minority shareholders
|
|
-
|
|
(10)
|
|
Cash dividends paid:
|
|
|
|
|
|
- Parent company shareholders
|
|
(2,541)
|
|
(2,404)
|
|
- Minority shareholders
|
|
(130)
|
|
(127)
|
|
Net issuance (repayment) of non-current debt
|
|
4,237
|
|
3,444
|
|
Increase (decrease) in current borrowings
|
|
(3,015)
|
|
(807)
|
|
Increase (decrease) in current financial assets and liabilities
|
|
-
|
|
821
|
|
Cash flow (from) / used in financing activities
|
|
(1,427)
|
|
130
|
|
Net increase (decrease) in cash and cash equivalents
|
|
1,356
|
|
7,466
|
|
Effect of exchange rates
|
|
98
|
|
(223)
|
|
Cash and cash equivalents at the beginning of the period
|
|
12,321
|
|
5,988
|
|
Cash and cash equivalents at the end of the period
|
|
13,775
|
|
13,231
|
|
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
|
|
TOTAL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issued
|
|
Paid-in surplus and retained earnings
|
|
Currency translation adjustment
|
|
Treasury shares
|
|
Shareholders' equity Group Share
|
|
Minority interests
|
|
Total shareholders' equity
|
|
|
(M€)
|
Number
|
|
Amount
|
|
|
|
Number
|
|
Amount
|
|
|
|
|
|
As of January 1, 2008
|
2,395,532,097
|
|
5,989
|
|
48,797
|
|
(4,396)
|
|
(151,421,232)
|
|
(5,532)
|
|
44,858
|
|
842
|
|
45,700
|
|
|
Net income for the first nine months
|
-
|
|
-
|
|
11,384
|
|
-
|
|
-
|
|
-
|
|
11,384
|
|
345
|
|
11,729
|
|
|
Other comprehensive Income
|
-
|
|
-
|
|
(153)
|
|
333
|
|
-
|
|
-
|
|
180
|
|
(59)
|
|
121
|
|
|
Comprehensive Income
|
-
|
|
-
|
|
11,231
|
|
333
|
|
-
|
|
-
|
|
11,564
|
|
286
|
|
11,850
|
|
|
Dividend
|
-
|
|
-
|
|
(4,949)
|
|
-
|
|
-
|
|
-
|
|
(4,949)
|
|
(127)
|
|
(5,076)
|
|
|
Issuance of common shares
|
6,103,524
|
|
15
|
|
243
|
|
-
|
|
-
|
|
-
|
|
258
|
|
-
|
|
258
|
|
|
Purchase of treasury shares
|
-
|
|
-
|
|
-
|
|
-
|
|
(24,000,000)
|
|
(1,194)
|
|
(1,194)
|
|
-
|
|
(1,194)
|
| | |